References
1. Lagatta JM, Clark RH, Brousseau DC, Hoffmann RG, Spitzer AR. Varying
patterns of home oxygen use in infants at 23-43 weeks’ gestation
discharged from United States neonatal intensive care units. J
Pediatr. 2013;163(4):976-982 e972.
2. Bhandari A, Panitch H. An update on the post-NICU discharge
management of bronchopulmonary dysplasia. Semin Perinatol.2018;42(7):471-477.
3. Stewart A, Brion LP, Ambrosio-Perez I. Diuretics acting on the distal
renal tubule for preterm infants with (or developing) chronic lung
disease. Cochrane Database Syst Rev. 2011(9):CD001817.
4. White H, Berenson A, Mannan J, Feldman HA, Rhein L, Group RHOS.
Utilization trends of respiratory medication in premature infants
discharged on home oxygen therapy. Pediatr Pulmonol.2020;55(6):1359-1365.
5. Ryan RM, Keller RL, Poindexter BB, et al. Respiratory Medications in
Infants <29 Weeks during the First Year Postdischarge: The
Prematurity and Respiratory Outcomes Program (PROP) Consortium. J
Pediatr. 2019;208:148-155 e143.
6. Cristea AI, Ren CL, Amin R, et al. Outpatient Respiratory Management
of Infants, Children, and Adolescents with Post-Prematurity Respiratory
Disease: An Official American Thoracic Society Clinical Practice
Guideline. Am J Respir Crit Care Med. 2021;204(12):e115-e133.
7. Dawson SK, D’Andrea LA, Lau R, Lagatta JM. Using a home oxygen
weaning protocol and pCO2 to evaluate outcomes for infants with
bronchopulmonary dysplasia discharged on home oxygen. Pediatr
Pulmonol. 2020;55(12):3293-3303.
8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir
Crit Care Med. 2001;163(7):1723-1729.
9. Jensen EA, Dysart K, Gantz MG, et al. The Diagnosis of
Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based
Approach. Am J Respir Crit Care Med. 2019;200(6):751-759.
10. Kao LC, Durand DJ, Phillips BL, Nickerson BG. Oral theophylline and
diuretics improve pulmonary mechanics in infants with bronchopulmonary
dysplasia. J Pediatr. 1987;111(3):439-444.
11. Kao LC, Warburton D, Cheng MH, Cedeno C, Platzker AC, Keens TG.
Effect of oral diuretics on pulmonary mechanics in infants with chronic
bronchopulmonary dysplasia: results of a double-blind crossover
sequential trial. Pediatrics. 1984;74(1):37-44.
12. Baraldi E, Filippone M. Chronic lung disease after premature birth.N Engl J Med. 2007;357(19):1946-1955.
13. Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of
the child with chronic lung disease of infancy and childhood. Am J
Respir Crit Care Med. 2003;168(3):356-396.
14. Kao LC, Durand DJ, McCrea RC, Birch M, Powers RJ, Nickerson BG.
Randomized trial of long-term diuretic therapy for infants with
oxygen-dependent bronchopulmonary dysplasia. J Pediatr.1994;124(5 Pt 1):772-781.
15. Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the
bronchopulmonary dysplasia group. Pediatrics. 2006;117(3 Pt
2):S52-56.
16. Slaughter JL, Stenger MR, Reagan PB. Variation in the use of
diuretic therapy for infants with bronchopulmonary dysplasia.Pediatrics. 2013;131(4):716-723.
17. Bhandari A, Chow U, Hagadorn JI. Variability in duration of
outpatient diuretic therapy in bronchopulmonary dysplasia: a clinical
experience. Am J Perinatol. 2010;27(7):529-535.
18. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Utilization of
inhaled corticosteroids for infants with bronchopulmonary dysplasia.PLoS One. 2014;9(9):e106838.